ASP Isotopes (STU:W62) EBIT: €-151.14 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:W62 ASP Isotopes Inc STU:W62
14 GF Score
Price €3.43
! 7 Warning Signs
View Full Analysis

What is ASP Isotopes EBIT?

ASP Isotopes STU:W62 +0.26% 14 EBIT is €-151.14 Mil as of Mar. 2026. GuruFocus rates STU:W62 with a GF Score™ of 14/100. The stock has 7 warning signs investors should review.

ASP Isotopes's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was €-21.63 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was €-151.14 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. ASP Isotopes's annualized ROC % for the quarter that ended in Mar. 2026 was -40.18%. ASP Isotopes's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -74.78%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. ASP Isotopes's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -46.00%.

ASP Isotopes  (STU:W62) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

ASP Isotopes's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=-86.112 * ( 1 - 0.12% )/( (138.753 + 289.369)/ 2 )
=-86.0086656/214.061
=-40.18 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=425.309 - 7.027 - ( 279.529 - max(0, 27.922 - 341.531+279.529))
=138.753

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=508.334 - 12.772 - ( 251.296 - max(0, 60.867 - 267.06+251.296))
=289.369

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

ASP Isotopes's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-86.528/( ( (29.681 + max(7.203, 0)) + (194.526 + max(-0.10399999999999, 0)) )/ 2 )
=-86.528/( ( 36.884 + 194.526 )/ 2 )
=-86.528/115.705
=-74.78 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.921 + 0.938 + 32.16) - (7.027 + 0.753 + 19.036)
=7.203

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2.07 + 1.184 + 10.61) - (12.772 + 0.763 + 0.433)
=-0.10399999999999

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

ASP Isotopes's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=-151.143/328.551
=-46.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ASP Isotopes EBIT Related Terms

ASP Isotopes EBIT Historical Data

* Premium members only.

The historical data trend for ASP Isotopes's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ASP Isotopes EBIT Chart

ASP Isotopes Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
0.00 -4.67 -14.84 -30.61 -151.13

ASP Isotopes Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.81 -65.01 -10.80 -53.71 -21.63

STU:W62 vs LXU, WLKP, ASIX: EBIT Comparison

For the Chemicals subindustry, ASP Isotopes's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ASP Isotopes EV-to-EBIT vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, ASP Isotopes's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where ASP Isotopes's EV-to-EBIT falls into.


STU:W62
14GF Score
ASP Isotopes Inc STU:W62
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ASP Isotopes EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-151.14 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €-151.14 Mil mean?
ASP Isotopes (STU:W62) has a EBIT of €-151.14 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on ASP Isotopes.
Is ASP Isotopes' EBIT too high?
ASP Isotopes' current EBIT is €-151.14 Mil. Overall, ASP Isotopes has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does ASP Isotopes' EBIT compare to LXU and WLKP?
ASP Isotopes' EBIT of €-151.14 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Chemicals company?
A good EBIT depends on the Chemicals industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on ASP Isotopes. ASP Isotopes's current EBIT is €-151.14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ASP Isotopes stock overvalued right now?
ASP Isotopes (STU:W62) has a current EBIT of €-151.14 Mil. The current EBIT is €-151.14 Mil. ASP Isotopes' overall GF Score™ is 14/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For ASP Isotopes (STU:W62), the current EBIT is €-151.14 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ASP Isotopes Business Description

Address 2200 Ross Avenue, Suite 4575 East, Dallas, TX, USA, 75201
ASP Isotopes Inc is a materials company focused on producing and commercializing enriched isotopes for the nuclear medicine, healthcare, green energy, and quantum computing industries. Currently, the company has three operating segments: (i) nuclear fuels, (ii) specialist isotopes and related services, and (iii) construction services. Using proprietary technology-the Aerodynamic Separation Process (ASP)-the company enriches isotopes in South Africa, targeting high-value, low-volume markets to reduce reliance on foreign supply chains. Geographically, the company operates in South Africa, Hong Kong and United States generating key revenue from the Hong Kong region.
14GF Score

Get the complete analysis for STU:W62

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.43
Price